Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1)

Table 1 Analysis of the correlation between expression of miR-493 in primary NSCLC and its clinicopathological parameters

clinicopathological rameters	Total cases	High expression	Low expression	P-value
Total patients	195	66	129
Age (years)				0.365
≥60	117	36	81
<60	78	30	48
Sex				0.450
Male	135	42	93
Female	60	24	36
Stage (NSCLC)				0.215
I, II	114	51	63
III+ IV	81	15	66
Histology				0.511
SCC	75	30	45
Adenocarcinoma	84	24	60
Others	36	12	24
Metastasis status				0.065
Metastasis	84	15	69
No metastasis	111	51	60

ISSN: 1756-9966